Charles River Laboratories | CRL - Sales Revenues

Stock Price
174.90
Daily Change
2.40 1.39%
Monthly
-2.08%
Yearly
17.16%
Q2 Forecast
154.39

Charles River Laboratories reported $994.2M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Agilent USD 1.8B 63M Dec/2025
Align Technology USD 1.05B 54.3M Dec/2025
Bio-Rad Laboratories USD 693.2M 40.2M Dec/2025
Bruker USD 977.2M 116.7M Dec/2025
Cardinal Health USD 65.63B 1.63B Dec/2025
Charles River Laboratories USD 994.2M 5.8M Dec/2025
Cigna USD 72.47B 2.77B Dec/2025
Concord Medical Services Hldg CNY 200.61M 83.9M Jun/2025
CVS Health USD 105.7B 2.8B Dec/2025
Danaher USD 6.84B 790M Dec/2025
Dentsply International USD 961M 57M Dec/2025
Elevance Health USD 49.3B 790M Dec/2025
Galapagos EUR 900.82M 835.52M Dec/2025
Hologic USD 1.05B 0 Dec/2025
Humana USD 32.52B 130M Dec/2025
Illumina USD 1.16B 80M Dec/2025
Incyte USD 1.51B 140M Dec/2025
Intrexon USD 717K 511K Jun/2024
IQVIA Holdings USD 4.36B 260M Dec/2025
Laboratory Of America USD 3.52B 40M Dec/2025
Lonza CHF 3.58B 63M Jun/2025
McKesson USD 106.16B 3.01B Dec/2025
Merck EUR 5.25B 70M Dec/2025
Mettler Toledo International USD 1.13B 100M Dec/2025
Novartis USD 13.86B 50M Dec/2025
Pfizer USD 17.58B 880M Dec/2025
Quest Diagnostics USD 2.81B 10M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
United Therapeutics USD 790.2M 9.3M Dec/2025
UnitedHealth USD 113.2B 0 Dec/2025
Veradigm USD 142.52M 9.38M Dec/2022
Waters USD 932M 132M Dec/2025
West Pharmaceutical Services USD 805M 400K Dec/2025